- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.98 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x LYS: LYSINE(Covalent)
- 10 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 3 residues within 4Å:- Chain A: E.98, F.99, R.122
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:F.99
- Water bridges: A:E.98
- Salt bridges: A:R.122
SO4.3: 2 residues within 4Å:- Chain A: H.286, Y.287
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Y.287
- Salt bridges: A:H.286
SO4.4: 2 residues within 4Å:- Chain A: G.109, R.110
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.110
- Water bridges: A:D.111, A:D.111
- Salt bridges: A:R.110
SO4.12: 3 residues within 4Å:- Chain B: G.285, H.286, Y.287
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Y.287
- Salt bridges: B:H.286
SO4.13: 2 residues within 4Å:- Chain B: G.109, R.110
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.110
- Water bridges: B:D.111
- Salt bridges: B:R.110
SO4.22: 3 residues within 4Å:- Chain C: E.98, F.99, R.122
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:F.99
- Salt bridges: C:R.122
SO4.23: 2 residues within 4Å:- Chain C: H.286, Y.287
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:Y.287
- Salt bridges: C:H.286
SO4.24: 2 residues within 4Å:- Chain C: G.109, R.110
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:R.110
- Water bridges: C:D.111, C:D.111
- Salt bridges: C:R.110
SO4.32: 3 residues within 4Å:- Chain D: G.285, H.286, Y.287
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Y.287
- Salt bridges: D:H.286
SO4.33: 2 residues within 4Å:- Chain D: G.109, R.110
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:R.110
- Water bridges: D:D.111
- Salt bridges: D:R.110
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 6 residues within 4Å:- Chain A: L.106, L.107, N.459, P.460, V.461, C.490
Ligand excluded by PLIPEDO.6: 3 residues within 4Å:- Chain A: Y.577, W.587, N.611
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: N.21, D.51, E.52
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: I.29, V.256, P.301, R.305
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: R.271, L.349, K.352, A.407
- Ligands: EDO.10
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: R.271, Y.280, G.285
- Ligands: EDO.9
Ligand excluded by PLIPEDO.15: 2 residues within 4Å:- Chain B: N.515, Y.619
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain B: L.106, L.107, N.459, P.460, V.461, C.490
Ligand excluded by PLIPEDO.17: 3 residues within 4Å:- Chain B: N.21, D.51, E.52
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain B: S.432, D.433, M.434
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain B: I.29, V.256, P.301, R.305
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain B: R.329, G.331, F.421, A.423
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain C: L.106, L.107, N.459, P.460, V.461, C.490
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain C: Y.577, W.587, N.611
Ligand excluded by PLIPEDO.27: 3 residues within 4Å:- Chain C: N.21, D.51, E.52
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain C: I.29, V.256, P.301, R.305
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain C: R.271, L.349, K.352, A.407
- Ligands: EDO.30
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain C: R.271, Y.280, G.285
- Ligands: EDO.29
Ligand excluded by PLIPEDO.35: 2 residues within 4Å:- Chain D: N.515, Y.619
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain D: L.106, L.107, N.459, P.460, V.461, C.490
Ligand excluded by PLIPEDO.37: 3 residues within 4Å:- Chain D: N.21, D.51, E.52
Ligand excluded by PLIPEDO.38: 3 residues within 4Å:- Chain D: S.432, D.433, M.434
Ligand excluded by PLIPEDO.39: 4 residues within 4Å:- Chain D: I.29, V.256, P.301, R.305
Ligand excluded by PLIPEDO.40: 4 residues within 4Å:- Chain D: R.329, G.331, F.421, A.423
Ligand excluded by PLIP- 2 x DIO: 1,4-DIETHYLENE DIOXIDE(Non-covalent)
DIO.14: 7 residues within 4Å:- Chain B: G.615, N.617, P.677, V.678, F.679
- Chain D: V.662, L.676
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:F.679
- Water bridges: B:N.617, B:N.617
DIO.34: 7 residues within 4Å:- Chain B: V.662, L.676
- Chain D: G.615, N.617, P.677, V.678, F.679
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:F.679
- Water bridges: D:N.617, D:N.617
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Okazaki, S. et al., X-Ray crystallographic evidence for the presence of the cysteine tryptophylquinone cofactor in L-lysine {varepsilon}-oxidase from Marinomonas mediterranea. J.Biochem. (2013)
- Release Date
- 2013-09-04
- Peptides
- L-lysine 6-oxidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.98 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x LYS: LYSINE(Covalent)
- 10 x SO4: SULFATE ION(Non-functional Binders)
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x DIO: 1,4-DIETHYLENE DIOXIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Okazaki, S. et al., X-Ray crystallographic evidence for the presence of the cysteine tryptophylquinone cofactor in L-lysine {varepsilon}-oxidase from Marinomonas mediterranea. J.Biochem. (2013)
- Release Date
- 2013-09-04
- Peptides
- L-lysine 6-oxidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B